GLP1R and diabetic kidney disease: Given the well-established role of EMT in CKD and DKD progression and the spectacular nephroprotective and cardioprotective effects of SGLT2i and GLP1-R agonists, it may also be interesting to look whether these drugs interact with EMT and EndMT.